131 related articles for article (PubMed ID: 16150196)
1. Clinical study on treatment of primary hepatocellular carcinoma by Shenqi mixture combined with microwave coagulation.
Lin JJ; Jin CN; Zheng ML; Ouyang XN; Zeng JX; Dai XH
Chin J Integr Med; 2005 Jun; 11(2):104-10. PubMed ID: 16150196
[TBL] [Abstract][Full Text] [Related]
2. Effects of Fufang Banmao Capsule Associated with Sorafenib on Liver Function, Immune Status, Quality of Life Improvement, and Survival in Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Study.
Lai X; Wang A
Comput Intell Neurosci; 2022; 2022():6336107. PubMed ID: 36052044
[TBL] [Abstract][Full Text] [Related]
3. Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
Pan CC; Huang ZL; Li W; Zhao M; Zhou QM; Xia JC; Wu PH
Chin J Cancer; 2010 Jun; 29(6):596-602. PubMed ID: 20507732
[TBL] [Abstract][Full Text] [Related]
4. Comparison of therapeutic effects between radiofrequency ablation and percutaneous microwave coagulation therapy for small hepatocellular carcinomas.
Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
J Gastroenterol Hepatol; 2009 Feb; 24(2):223-7. PubMed ID: 18823439
[TBL] [Abstract][Full Text] [Related]
5. Microwave coagulation therapy for unresectable hepatocellular carcinoma.
Aramaki M; Kawano K; Ohno T; Sasaki A; Tahara K; Kai S; Iwashita Y; Kitano S
Hepatogastroenterology; 2004; 51(60):1784-7. PubMed ID: 15532826
[TBL] [Abstract][Full Text] [Related]
6. [Indication of percutaneous microwave coagulation therapy for hepatocellular carcinoma].
Tabuse K; Tsuji T
Gan To Kagaku Ryoho; 1999 Oct; 26(12):1684-8. PubMed ID: 10560371
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the efficacy of aparatinib and carrilizumab combined with transcatheter arterial chemoembolization in the treatment of primary hepatocellular carcinoma.
Chen C; Duan XT; Li GY; Hao XJ; Wang WL; Shen YF; Zhang SH
Eur Rev Med Pharmacol Sci; 2023 May; 27(9):4135-4144. PubMed ID: 37203839
[TBL] [Abstract][Full Text] [Related]
8. Effect of Xiaoaiping injection on advanced hepatocellular carcinoma in patients.
Huang Z; Wang Y; Chen J; Wang R; Chen Q
J Tradit Chin Med; 2013 Feb; 33(1):34-8. PubMed ID: 23596809
[TBL] [Abstract][Full Text] [Related]
9. Analysis on efficacy and safety of TACE in combination with RFA and MWA in the treatment of middle and large primary hepatic carcinoma.
Yuan P; Zhang Z; Kuai J
J BUON; 2019; 24(1):163-170. PubMed ID: 30941966
[TBL] [Abstract][Full Text] [Related]
10. [Influence of microwave ablation and surgical resection of small primary hepatocellular carcinoma on hematogenous dissemination of tumor cells].
Dong BW; Wen CY; Liang P; Yu XL; Su L; Yu DJ; Xia HT
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):39-42. PubMed ID: 16737619
[TBL] [Abstract][Full Text] [Related]
11. Standards for selecting percutaneous ethanol injection therapy or percutaneous microwave coagulation therapy for solitary small hepatocellular carcinoma: consideration of local recurrence.
Horigome H; Nomura T; Saso K; Itoh M
Am J Gastroenterol; 1999 Jul; 94(7):1914-7. PubMed ID: 10406259
[TBL] [Abstract][Full Text] [Related]
12. Microwave coagulation therapy for hepatocellular carcinoma.
Midorikawa T; Kumada K; Kikuchi H; Ishibashi K; Yagi H; Nagasaki H; Nemoto H; Saitoh M; Nakano H; Yamaguchi M; Koh Y; Sakai H; Yoshizawa Y; Sanada Y; Yoshiba M
J Hepatobiliary Pancreat Surg; 2000; 7(3):252-9. PubMed ID: 10982623
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of Fuzheng Yiliu Recipe combined with microwave ablation on hepatocellular carcinoma].
Zhao HJ; Du J; Chen X
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Jan; 32(1):32-4. PubMed ID: 22500387
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous microwave coagulation therapy for patients with small hepatocellular carcinoma: comparison with percutaneous ethanol injection therapy.
Seki T; Wakabayashi M; Nakagawa T; Imamura M; Tamai T; Nishimura A; Yamashiki N; Okamura A; Inoue K
Cancer; 1999 Apr; 85(8):1694-702. PubMed ID: 10223562
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of microwave ablation in treatment of hepatocellular carcinoma within the Milan criteria: a report of 696 cases].
Wang YM; Qian GJ; Xu Y; Wang N; Sheng YH
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):344-348. PubMed ID: 28763840
[No Abstract] [Full Text] [Related]
16. Predictive Factors of Tumor Recurrence and Survival in Patients with Hepatocellular Carcinoma treated with Transarterial Chemoembolization.
Cerban R; Ester C; Iacob S; Grasu M; Pâslaru L; Dumitru R; Lupescu I; Constantin G; Croitoru A; Gheorghe L
J Gastrointestin Liver Dis; 2018 Dec; 27(4):409-417. PubMed ID: 30574623
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for local and distant recurrence of hepatocellular carcinomas after local ablation therapies.
Nouso K; Matsumoto E; Kobayashi Y; Nakamura S; Tanaka H; Osawa T; Ikeda H; Araki Y; Sakaguchi K; Shiratori Y
J Gastroenterol Hepatol; 2008 Mar; 23(3):453-8. PubMed ID: 17725599
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the mRECIST and α-fetoprotein ratio for stratification of the prognosis of advanced-hepatocellular-carcinoma patients treated with sorafenib.
Kawaoka T; Aikata H; Murakami E; Nakahara T; Naeshiro N; Tanaka M; Honda Y; Miyaki D; Nagaoki Y; Takaki S; Hiramatsu A; Waki K; Takahashi S; Chayama K
Oncology; 2012; 83(4):192-200. PubMed ID: 22890083
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with transcatheter arterial chemoembolization and percutaneous microwave coagulation therapy for hepatocellular carcinoma.
Seki T; Tamai T; Nakagawa T; Imamura M; Nishimura A; Yamashiki N; Ikeda K; Inoue K
Cancer; 2000 Sep; 89(6):1245-51. PubMed ID: 11002219
[TBL] [Abstract][Full Text] [Related]
20. Early Changes in Alpha-Fetoprotein Are a Useful Predictor of Efficacy of Atezolizumab plus Bevacizumab Treatment in Patients with Advanced Hepatocellular Carcinoma.
Kuzuya T; Kawabe N; Hashimoto S; Miyahara R; Sawaki A; Nakano T; Nakaoka K; Tanaka H; Miyachi Y; Mii A; Kamejima S; Takahara T; Kato Y; Sugioka A; Hirooka Y
Oncology; 2022; 100(1):12-21. PubMed ID: 34731863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
